Ninety One Uk LTD Eli Lilly & CO Transaction History

Ninety One Uk LTD

$34.4 Billion
Q1 2025

A detailed history of Ninety One Uk LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Ninety One Uk LTD holds 306,738 shares of LLY stock, worth $272 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

306,738

Previous 283,101 8.35%

Holding current value

$272 Million

Previous $219 Million 15.92%

% of portfolio

0.74%

Previous 0.61%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$725.72 - $929.72 $17.2 Million - $22 Million	23,637 Added 8.35%	306,738 $253 Million
Q4 2024 Jan 27, 2025	SELL	$727.2 - $932.06 $18.9 Million - $24.3 Million	-26,031 Reduced 8.42%	283,101 $219 Million
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $219 Million - $272 Million	283,736 Added 1117.25%	309,132 $274 Million
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $15 Million - $20.1 Million	25,396 New	25,396 $19.8 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $5 Million - $6.89 Million	-11,503 Reduced 33.46%	22,878 $12.3 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $6 Million - $8.02 Million	-17,101 Reduced 33.22%	34,381 $16.1 Million
Q1 2023 Apr 28, 2023	BUY	$310.63 - $364.82 $105,614 - $124,038	340 Added 0.66%	51,482 $17.7 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $3.11 Million - $3.62 Million	-9,664 Reduced 15.89%	51,142 $18.7 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $18 Million - $20.5 Million	60,806 New	60,806 $19.7 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $10,045 - $13,292	-77 Closed	0 $0
Q2 2020 Sep 04, 2020	SELL	$136.42 - $164.18 $5.12 Million - $6.16 Million	-37,516 Reduced 99.8%	77 $13,000
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $142 Million - $175 Million	-1,324,282 Reduced 97.24%	37,593 $4.94 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $1.7 Million - $1.85 Million	15,908 Added 1.18%	1,361,875 $152 Million
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $54.9 Million - $64 Million	-495,208 Reduced 26.9%	1,345,967 $149 Million
Q1 2019 Apr 24, 2019	SELL	$111.31 - $131.02 $14.2 Million - $16.7 Million	-127,430 Reduced 6.47%	1,841,175 $239 Million
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $76 Million - $85.1 Million	-717,564 Reduced 26.71%	1,968,605 $228 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $13.6 Million - $16.9 Million	157,890 Added 6.24%	2,686,169 $288 Million
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $63.5 Million - $72.8 Million	838,271 Added 49.6%	2,528,279 $216 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $18.3 Million - $21.6 Million	-246,646 Reduced 12.74%	1,690,008 $131 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $159 Million - $170 Million	1,936,654	1,936,654 $164 Million

Others Institutions Holding LLY

# of Institutions

4,336

Shares Held

759M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $841B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninety One Uk LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ninety One Uk LTD with notifications on news.

Account